Plannning & Management
Our company’s domain area is somatic stem cells and these cells have functions of cell differentiation. Notably, it is generally considered that somatic stem cells which are isolated from a client’s body and cultivated in vitro are less likely to be rejected after returning to the client’s body.
Nonetheless, regarding the analysis of the abnormal growth of cancer cells, we are promoting partnerships with medical institutions and laboratory centers not only in Japan, but also overseas. We are committed to moving beyond the normal practices of today, and furthering the advancement of the utilization of precision medicine in medical institutions.
Those patients are required to receive regular face-to-face medical treatment and prescription. They usually spend longer hours waiting in an office until they receive a medical treatment. These long hours of waiting lead to patients’ giving up their treatment and more severe diabetic conditions.
we will strive for contribution to medical development and efficiency by combining common data from each independent medical institution.
We proactively invest in our domain organizations including medical institutions, general companies, venture companies, and others dealing in the following areas:
We plan and develop a medical building after receiving an order from a property owner.
we transform a general building into a medical specific building with facilities including laboratories and a new medical department, which conventional medical institutions cannot obtain, and we lease it to a major medical institution.